1. Home
  2. VVPR vs BCLI Comparison

VVPR vs BCLI Comparison

Compare VVPR & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVPR
  • BCLI
  • Stock Information
  • Founded
  • VVPR 2014
  • BCLI 2000
  • Country
  • VVPR United Kingdom
  • BCLI United States
  • Employees
  • VVPR N/A
  • BCLI N/A
  • Industry
  • VVPR Power Generation
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VVPR Utilities
  • BCLI Health Care
  • Exchange
  • VVPR Nasdaq
  • BCLI Nasdaq
  • Market Cap
  • VVPR 10.9M
  • BCLI 9.1M
  • IPO Year
  • VVPR 2016
  • BCLI N/A
  • Fundamental
  • Price
  • VVPR $1.44
  • BCLI $2.37
  • Analyst Decision
  • VVPR
  • BCLI Strong Buy
  • Analyst Count
  • VVPR 0
  • BCLI 1
  • Target Price
  • VVPR N/A
  • BCLI $30.00
  • AVG Volume (30 Days)
  • VVPR 1.0M
  • BCLI 126.7K
  • Earning Date
  • VVPR 01-07-2025
  • BCLI 11-14-2024
  • Dividend Yield
  • VVPR N/A
  • BCLI N/A
  • EPS Growth
  • VVPR N/A
  • BCLI N/A
  • EPS
  • VVPR N/A
  • BCLI N/A
  • Revenue
  • VVPR $16,000.00
  • BCLI N/A
  • Revenue This Year
  • VVPR N/A
  • BCLI N/A
  • Revenue Next Year
  • VVPR N/A
  • BCLI N/A
  • P/E Ratio
  • VVPR N/A
  • BCLI N/A
  • Revenue Growth
  • VVPR N/A
  • BCLI N/A
  • 52 Week Low
  • VVPR $0.72
  • BCLI $1.05
  • 52 Week High
  • VVPR $9.90
  • BCLI $11.85
  • Technical
  • Relative Strength Index (RSI)
  • VVPR 65.99
  • BCLI 65.84
  • Support Level
  • VVPR $1.26
  • BCLI $2.02
  • Resistance Level
  • VVPR $1.53
  • BCLI $2.50
  • Average True Range (ATR)
  • VVPR 0.15
  • BCLI 0.23
  • MACD
  • VVPR 0.02
  • BCLI 0.10
  • Stochastic Oscillator
  • VVPR 97.83
  • BCLI 93.69

About VVPR VivoPower International PLC

Vivopower International PLC is a solar power company. The company provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Critical Power Services segment which consists of the design, supply, installation, and maintenance of power and control systems. It provides its solutions to government, commercial, and industrial customers. Nearly all of the revenue derives from Australia.

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Share on Social Networks: